Loading…

Expression of functional NK 1 receptors in human alveolar macrophages: superoxide anion production, cytokine release and involvement of NF‐ κ B pathway

Substance P (SP) is deeply involved in lung pathophysiology and plays a key role in the modulation of inflammatory‐immune processes. We previously demonstrated that SP activates guinea‐pig alveolar macrophages (AMs) and human monocytes, but a careful examination of its effects on human AMs is still...

Full description

Saved in:
Bibliographic Details
Published in:British journal of pharmacology 2009-01, Vol.145 (3), p.385-396
Main Authors: Bardelli, Claudio, Gunella, Gabriele, Varsaldi, Federica, Balbo, Pietro, Del Boca, Elisa, Bernardone, Ilaria Seren, Amoruso, Angela, Brunelleschi, Sandra
Format: Article
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c848-357b3ca3fe715c7e52b70889dce29dc6630ff85be8f2dc00f11e76b87f53b0613
cites cdi_FETCH-LOGICAL-c848-357b3ca3fe715c7e52b70889dce29dc6630ff85be8f2dc00f11e76b87f53b0613
container_end_page 396
container_issue 3
container_start_page 385
container_title British journal of pharmacology
container_volume 145
creator Bardelli, Claudio
Gunella, Gabriele
Varsaldi, Federica
Balbo, Pietro
Del Boca, Elisa
Bernardone, Ilaria Seren
Amoruso, Angela
Brunelleschi, Sandra
description Substance P (SP) is deeply involved in lung pathophysiology and plays a key role in the modulation of inflammatory‐immune processes. We previously demonstrated that SP activates guinea‐pig alveolar macrophages (AMs) and human monocytes, but a careful examination of its effects on human AMs is still scarce. This study was undertaken to establish the role of SP in human AM isolated from healthy smokers and non‐smokers, by evaluating the presence of tachykinin NK 1 receptors (NK‐1R) and SP's ability to induce superoxide anion (O 2 − ) production and cytokine release, as well as activation of the nuclear factor‐ κ B (NF‐ κ B) pathway. By Western blot analysis and immunofluorescence, we demonstrate that authentic NK‐1R are present on human AMs, a three‐fold enhanced expression being observed in healthy smokers. These NK‐1R are functional, as SP and NK 1 agonists dose‐dependently induce O 2 − production and cytokine release. In AMs from healthy smokers, SP evokes an enhanced respiratory burst and a significantly increased release of tumor necrosis factor‐ α as compared to healthy non‐smokers, but has inconsistent effects on IL‐10 release. The NK 1 selective antagonist CP 96,345 ((2 S ,3 S )‐ cis ‐2‐diphenylmethyl‐ N [(2‐methoxyphenyl)‐methyl]‐1‐azabicyclo‐octan‐3‐amine)) competitively antagonized SP‐induced effects. SP activates the transcription factor NF‐ κ B, a three‐fold increased nuclear translocation being observed in AMs from healthy smokers. This effect is receptor‐mediated, as it is reproduced by the NK 1 selective agonist [Sar 9 Met(O 2 ) 11 ]SP and reverted by CP 96,345. These results clearly indicate that human AMs possess functional NK‐1R on their surface, which are upregulated in healthy smokers, providing new insights on the mechanisms involved in tobacco smoke toxicity. British Journal of Pharmacology (2005) 145 , 385–396. doi: 10.1038/sj.bjp.0706198
doi_str_mv 10.1038/sj.bjp.0706198
format article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1038_sj_bjp_0706198</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1038_sj_bjp_0706198</sourcerecordid><originalsourceid>FETCH-LOGICAL-c848-357b3ca3fe715c7e52b70889dce29dc6630ff85be8f2dc00f11e76b87f53b0613</originalsourceid><addsrcrecordid>eNotkEFOwzAQRS0EEqWwZe0DkGDXTeyyg6oFRFU23UeOM6YJSWzZaWl3HIE1R-EQHIKT4EA3MyP90RvNQ-iSkpgSJq59FeeVjQknKZ2IIzSgY55GCRP0GA0IITyiVIhTdOZ9RUgIeTJAn7OddeB9aVpsNNabVnVhljVePmGKHSiwnXEely1ebxrZYllvwdTS4UYqZ-xavoC_wX5jwZldWQCWbQ-zzhSbP9YVVvvOvJYtBFwN0vcrRQBuTUA10Hb95eX85_0Df3_hO2xlt36T-3N0omXt4eLQh2g1n62mD9Hi-f5xeruIlBiLiCU8Z0oyDZwmikMyyjkRYlIoGIWSpoxoLZIchB4VihBNKfA0F1wnLA-m2BDF_9jwjfcOdGZd2Ui3zyjJerGZr7IgNjuIZb9IznIj</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Expression of functional NK 1 receptors in human alveolar macrophages: superoxide anion production, cytokine release and involvement of NF‐ κ B pathway</title><source>Open Access: PubMed Central</source><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Bardelli, Claudio ; Gunella, Gabriele ; Varsaldi, Federica ; Balbo, Pietro ; Del Boca, Elisa ; Bernardone, Ilaria Seren ; Amoruso, Angela ; Brunelleschi, Sandra</creator><creatorcontrib>Bardelli, Claudio ; Gunella, Gabriele ; Varsaldi, Federica ; Balbo, Pietro ; Del Boca, Elisa ; Bernardone, Ilaria Seren ; Amoruso, Angela ; Brunelleschi, Sandra</creatorcontrib><description>Substance P (SP) is deeply involved in lung pathophysiology and plays a key role in the modulation of inflammatory‐immune processes. We previously demonstrated that SP activates guinea‐pig alveolar macrophages (AMs) and human monocytes, but a careful examination of its effects on human AMs is still scarce. This study was undertaken to establish the role of SP in human AM isolated from healthy smokers and non‐smokers, by evaluating the presence of tachykinin NK 1 receptors (NK‐1R) and SP's ability to induce superoxide anion (O 2 − ) production and cytokine release, as well as activation of the nuclear factor‐ κ B (NF‐ κ B) pathway. By Western blot analysis and immunofluorescence, we demonstrate that authentic NK‐1R are present on human AMs, a three‐fold enhanced expression being observed in healthy smokers. These NK‐1R are functional, as SP and NK 1 agonists dose‐dependently induce O 2 − production and cytokine release. In AMs from healthy smokers, SP evokes an enhanced respiratory burst and a significantly increased release of tumor necrosis factor‐ α as compared to healthy non‐smokers, but has inconsistent effects on IL‐10 release. The NK 1 selective antagonist CP 96,345 ((2 S ,3 S )‐ cis ‐2‐diphenylmethyl‐ N [(2‐methoxyphenyl)‐methyl]‐1‐azabicyclo‐octan‐3‐amine)) competitively antagonized SP‐induced effects. SP activates the transcription factor NF‐ κ B, a three‐fold increased nuclear translocation being observed in AMs from healthy smokers. This effect is receptor‐mediated, as it is reproduced by the NK 1 selective agonist [Sar 9 Met(O 2 ) 11 ]SP and reverted by CP 96,345. These results clearly indicate that human AMs possess functional NK‐1R on their surface, which are upregulated in healthy smokers, providing new insights on the mechanisms involved in tobacco smoke toxicity. British Journal of Pharmacology (2005) 145 , 385–396. doi: 10.1038/sj.bjp.0706198</description><identifier>ISSN: 0007-1188</identifier><identifier>EISSN: 1476-5381</identifier><identifier>DOI: 10.1038/sj.bjp.0706198</identifier><language>eng</language><ispartof>British journal of pharmacology, 2009-01, Vol.145 (3), p.385-396</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c848-357b3ca3fe715c7e52b70889dce29dc6630ff85be8f2dc00f11e76b87f53b0613</citedby><cites>FETCH-LOGICAL-c848-357b3ca3fe715c7e52b70889dce29dc6630ff85be8f2dc00f11e76b87f53b0613</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Bardelli, Claudio</creatorcontrib><creatorcontrib>Gunella, Gabriele</creatorcontrib><creatorcontrib>Varsaldi, Federica</creatorcontrib><creatorcontrib>Balbo, Pietro</creatorcontrib><creatorcontrib>Del Boca, Elisa</creatorcontrib><creatorcontrib>Bernardone, Ilaria Seren</creatorcontrib><creatorcontrib>Amoruso, Angela</creatorcontrib><creatorcontrib>Brunelleschi, Sandra</creatorcontrib><title>Expression of functional NK 1 receptors in human alveolar macrophages: superoxide anion production, cytokine release and involvement of NF‐ κ B pathway</title><title>British journal of pharmacology</title><description>Substance P (SP) is deeply involved in lung pathophysiology and plays a key role in the modulation of inflammatory‐immune processes. We previously demonstrated that SP activates guinea‐pig alveolar macrophages (AMs) and human monocytes, but a careful examination of its effects on human AMs is still scarce. This study was undertaken to establish the role of SP in human AM isolated from healthy smokers and non‐smokers, by evaluating the presence of tachykinin NK 1 receptors (NK‐1R) and SP's ability to induce superoxide anion (O 2 − ) production and cytokine release, as well as activation of the nuclear factor‐ κ B (NF‐ κ B) pathway. By Western blot analysis and immunofluorescence, we demonstrate that authentic NK‐1R are present on human AMs, a three‐fold enhanced expression being observed in healthy smokers. These NK‐1R are functional, as SP and NK 1 agonists dose‐dependently induce O 2 − production and cytokine release. In AMs from healthy smokers, SP evokes an enhanced respiratory burst and a significantly increased release of tumor necrosis factor‐ α as compared to healthy non‐smokers, but has inconsistent effects on IL‐10 release. The NK 1 selective antagonist CP 96,345 ((2 S ,3 S )‐ cis ‐2‐diphenylmethyl‐ N [(2‐methoxyphenyl)‐methyl]‐1‐azabicyclo‐octan‐3‐amine)) competitively antagonized SP‐induced effects. SP activates the transcription factor NF‐ κ B, a three‐fold increased nuclear translocation being observed in AMs from healthy smokers. This effect is receptor‐mediated, as it is reproduced by the NK 1 selective agonist [Sar 9 Met(O 2 ) 11 ]SP and reverted by CP 96,345. These results clearly indicate that human AMs possess functional NK‐1R on their surface, which are upregulated in healthy smokers, providing new insights on the mechanisms involved in tobacco smoke toxicity. British Journal of Pharmacology (2005) 145 , 385–396. doi: 10.1038/sj.bjp.0706198</description><issn>0007-1188</issn><issn>1476-5381</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNotkEFOwzAQRS0EEqWwZe0DkGDXTeyyg6oFRFU23UeOM6YJSWzZaWl3HIE1R-EQHIKT4EA3MyP90RvNQ-iSkpgSJq59FeeVjQknKZ2IIzSgY55GCRP0GA0IITyiVIhTdOZ9RUgIeTJAn7OddeB9aVpsNNabVnVhljVePmGKHSiwnXEely1ebxrZYllvwdTS4UYqZ-xavoC_wX5jwZldWQCWbQ-zzhSbP9YVVvvOvJYtBFwN0vcrRQBuTUA10Hb95eX85_0Df3_hO2xlt36T-3N0omXt4eLQh2g1n62mD9Hi-f5xeruIlBiLiCU8Z0oyDZwmikMyyjkRYlIoGIWSpoxoLZIchB4VihBNKfA0F1wnLA-m2BDF_9jwjfcOdGZd2Ui3zyjJerGZr7IgNjuIZb9IznIj</recordid><startdate>20090129</startdate><enddate>20090129</enddate><creator>Bardelli, Claudio</creator><creator>Gunella, Gabriele</creator><creator>Varsaldi, Federica</creator><creator>Balbo, Pietro</creator><creator>Del Boca, Elisa</creator><creator>Bernardone, Ilaria Seren</creator><creator>Amoruso, Angela</creator><creator>Brunelleschi, Sandra</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20090129</creationdate><title>Expression of functional NK 1 receptors in human alveolar macrophages: superoxide anion production, cytokine release and involvement of NF‐ κ B pathway</title><author>Bardelli, Claudio ; Gunella, Gabriele ; Varsaldi, Federica ; Balbo, Pietro ; Del Boca, Elisa ; Bernardone, Ilaria Seren ; Amoruso, Angela ; Brunelleschi, Sandra</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c848-357b3ca3fe715c7e52b70889dce29dc6630ff85be8f2dc00f11e76b87f53b0613</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bardelli, Claudio</creatorcontrib><creatorcontrib>Gunella, Gabriele</creatorcontrib><creatorcontrib>Varsaldi, Federica</creatorcontrib><creatorcontrib>Balbo, Pietro</creatorcontrib><creatorcontrib>Del Boca, Elisa</creatorcontrib><creatorcontrib>Bernardone, Ilaria Seren</creatorcontrib><creatorcontrib>Amoruso, Angela</creatorcontrib><creatorcontrib>Brunelleschi, Sandra</creatorcontrib><collection>CrossRef</collection><jtitle>British journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bardelli, Claudio</au><au>Gunella, Gabriele</au><au>Varsaldi, Federica</au><au>Balbo, Pietro</au><au>Del Boca, Elisa</au><au>Bernardone, Ilaria Seren</au><au>Amoruso, Angela</au><au>Brunelleschi, Sandra</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Expression of functional NK 1 receptors in human alveolar macrophages: superoxide anion production, cytokine release and involvement of NF‐ κ B pathway</atitle><jtitle>British journal of pharmacology</jtitle><date>2009-01-29</date><risdate>2009</risdate><volume>145</volume><issue>3</issue><spage>385</spage><epage>396</epage><pages>385-396</pages><issn>0007-1188</issn><eissn>1476-5381</eissn><abstract>Substance P (SP) is deeply involved in lung pathophysiology and plays a key role in the modulation of inflammatory‐immune processes. We previously demonstrated that SP activates guinea‐pig alveolar macrophages (AMs) and human monocytes, but a careful examination of its effects on human AMs is still scarce. This study was undertaken to establish the role of SP in human AM isolated from healthy smokers and non‐smokers, by evaluating the presence of tachykinin NK 1 receptors (NK‐1R) and SP's ability to induce superoxide anion (O 2 − ) production and cytokine release, as well as activation of the nuclear factor‐ κ B (NF‐ κ B) pathway. By Western blot analysis and immunofluorescence, we demonstrate that authentic NK‐1R are present on human AMs, a three‐fold enhanced expression being observed in healthy smokers. These NK‐1R are functional, as SP and NK 1 agonists dose‐dependently induce O 2 − production and cytokine release. In AMs from healthy smokers, SP evokes an enhanced respiratory burst and a significantly increased release of tumor necrosis factor‐ α as compared to healthy non‐smokers, but has inconsistent effects on IL‐10 release. The NK 1 selective antagonist CP 96,345 ((2 S ,3 S )‐ cis ‐2‐diphenylmethyl‐ N [(2‐methoxyphenyl)‐methyl]‐1‐azabicyclo‐octan‐3‐amine)) competitively antagonized SP‐induced effects. SP activates the transcription factor NF‐ κ B, a three‐fold increased nuclear translocation being observed in AMs from healthy smokers. This effect is receptor‐mediated, as it is reproduced by the NK 1 selective agonist [Sar 9 Met(O 2 ) 11 ]SP and reverted by CP 96,345. These results clearly indicate that human AMs possess functional NK‐1R on their surface, which are upregulated in healthy smokers, providing new insights on the mechanisms involved in tobacco smoke toxicity. British Journal of Pharmacology (2005) 145 , 385–396. doi: 10.1038/sj.bjp.0706198</abstract><doi>10.1038/sj.bjp.0706198</doi><tpages>12</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0007-1188
ispartof British journal of pharmacology, 2009-01, Vol.145 (3), p.385-396
issn 0007-1188
1476-5381
language eng
recordid cdi_crossref_primary_10_1038_sj_bjp_0706198
source Open Access: PubMed Central; Wiley-Blackwell Read & Publish Collection
title Expression of functional NK 1 receptors in human alveolar macrophages: superoxide anion production, cytokine release and involvement of NF‐ κ B pathway
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T20%3A53%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Expression%20of%20functional%20NK%201%20receptors%20in%20human%20alveolar%20macrophages:%20superoxide%20anion%20production,%20cytokine%20release%20and%20involvement%20of%20NF%E2%80%90%20%CE%BA%20B%20pathway&rft.jtitle=British%20journal%20of%20pharmacology&rft.au=Bardelli,%20Claudio&rft.date=2009-01-29&rft.volume=145&rft.issue=3&rft.spage=385&rft.epage=396&rft.pages=385-396&rft.issn=0007-1188&rft.eissn=1476-5381&rft_id=info:doi/10.1038/sj.bjp.0706198&rft_dat=%3Ccrossref%3E10_1038_sj_bjp_0706198%3C/crossref%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c848-357b3ca3fe715c7e52b70889dce29dc6630ff85be8f2dc00f11e76b87f53b0613%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true